These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21846900)

  • 21. Morphologic characteristics of late stent malapposition after drug-eluting stents implantation by optical coherence tomography follow-up.
    Hou JB; Liu HM; Ma LJ; Yang S; Meng LB; Han ZG; Zhang S; Yu B
    Chin Med J (Engl); 2010 Mar; 123(5):581-4. PubMed ID: 20367985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Optical coherence tomography for evaluation of neointimal proliferation after placement of a new drug eluting stent].
    Liu CF; Chen YD; Chen L; Sun ZJ; Gai LY; Liu HB; Tian F; Bai QC; Guo K
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1063-5. PubMed ID: 20501394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Letter by Kereiakes et al regarding article, "Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern".
    Kereiakes DJ; Mauri L; Kuntz RE
    Circulation; 2007 Oct; 116(16):e389; author reply e390. PubMed ID: 17938296
    [No Abstract]   [Full Text] [Related]  

  • 24. Letter by Agostini et al regarding article, "Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern".
    Agostoni P; Sangiorgi GM; Biondi-Zoccai GG
    Circulation; 2007 Oct; 116(16):e388; author reply e390. PubMed ID: 17938295
    [No Abstract]   [Full Text] [Related]  

  • 25. [Subacute thrombosis of drug eluting stent immediately after off-pump coronary artery bypass grafting].
    Shiiku C; Kikuchi Y; Mitsube K
    Kyobu Geka; 2010 Jul; 63(7):561-4. PubMed ID: 20662236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-eluting stents versus bare-metal stents for off-label indications: a propensity score-matched outcome study.
    Austin D; Oldroyd KG; McConnachie A; Slack R; Eteiba H; Flapan AD; Jennings KP; Northcote RJ; Pell AC; Starkey IR; Pell JP
    Circ Cardiovasc Interv; 2008 Aug; 1(1):45-52. PubMed ID: 20031654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
    Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry.
    Machecourt J; Danchin N; Lablanche JM; Fauvel JM; Bonnet JL; Marliere S; Foote A; Quesada JL; Eltchaninoff H; Vanzetto G;
    J Am Coll Cardiol; 2007 Aug; 50(6):501-8. PubMed ID: 17678732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-eluting stent thrombosis.
    Pilgrim T; Windecker S
    Minerva Cardioangiol; 2009 Oct; 57(5):611-20. PubMed ID: 19838151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proximal atherosclerotic lesion as a cause of very late stent thrombosis.
    Gaddam S; Rizvi M; Nimmagadda KC; Gala B; Nagrani T; Ghavami F; McCord D; Lafferty J
    Med Hypotheses; 2011 Apr; 76(4):500-2. PubMed ID: 21185657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Very late bare-metal stent thrombosis. A case report and review of the literature.
    Manjappa N; Agarwal A; Cavusoglu E
    J Invasive Cardiol; 2006 Jul; 18(7):E203-6. PubMed ID: 16816449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
    Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
    Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different vascular healing patterns with various drug-eluting stents in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: optical coherence tomographic findings.
    Fan C; Kim JS; Lee JM; Kim TH; Park SM; Wi J; Paik SI; Ko YG; Choi D; Hong MK; Jang Y
    Am J Cardiol; 2010 Apr; 105(7):972-6. PubMed ID: 20346315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical features of late stent thrombosis after successful sirolimus-eluting stent implantation].
    He JQ; Chen F; Zhang XL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Nov; 35(11):1010-4. PubMed ID: 18269821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
    Simsek C; Onuma Y; Magro M; de Boer S; Battes L; van Domburg RT; Boersma E; Serruys PW;
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):41-9. PubMed ID: 20310019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute coronary syndrome is an independent risk factor for late incomplete stent apposition after sirolimus-eluting stent implantation.
    Zhang RY; DU R; Zhu ZB; Zhang Q; Hu J; Lü AK; Zhang JS; Shen WF
    Chin Med J (Engl); 2008 Dec; 121(24):2504-8. PubMed ID: 19187586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study.
    Beijk MA; Klomp M; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; Tijssen JG; Piek JJ; de Winter RJ
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):189-95. PubMed ID: 21542109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study.
    Nakazawa G; Finn AV; Joner M; Ladich E; Kutys R; Mont EK; Gold HK; Burke AP; Kolodgie FD; Virmani R
    Circulation; 2008 Sep; 118(11):1138-45. PubMed ID: 18725485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos).
    de la Torre-Hernández JM; Alfonso F; Hernández F; Elizaga J; Sanmartin M; Pinar E; Lozano I; Vazquez JM; Botas J; Perez de Prado A; Hernández JM; Sanchis J; Nodar JM; Gomez-Jaume A; Larman M; Diarte JA; Rodríguez-Collado J; Rumoroso JR; Lopez-Minguez JR; Mauri J;
    J Am Coll Cardiol; 2008 Mar; 51(10):986-90. PubMed ID: 18325436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Re-occurred acute myocardial infarction caused by very late thrombosis 36 months after implantation of sirolimus eluting stent: a case report].
    Zhang GB; Sun BG; Wen QZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr; 35(4):368. PubMed ID: 17711671
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.